Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071907
Filing Date
2025-05-15
Accepted
2025-05-15 06:05:14
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20250331.htm   iXBRL 10-Q 2172853
2 EX-10.1 aura-ex10_1.htm EX-10.1 36201
3 EX-31.1 aura-ex31_1.htm EX-31.1 19067
4 EX-31.2 aura-ex31_2.htm EX-31.2 20119
5 EX-32.1 aura-ex32_1.htm EX-32.1 21862
6 GRAPHIC img110370785_0.jpg GRAPHIC 9004
  Complete submission text file 0000950170-25-071907.txt   8368392

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aura-20250331.xsd EX-101.SCH 1134391
77 EXTRACTED XBRL INSTANCE DOCUMENT aura-20250331_htm.xml XML 1324416
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 25948359
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)